A study led by the University of Oxford suggests that the Shingrix vaccine may lower the risk of cardiovascular events by 12% in older adults. If confirmed by further trials, this could provide a preventative health benefit comparable to daily blood pressure medication, potentially protecting thousands from heart disease and stroke.